Imidazo[1,2-a]pyridine-2-carboxamide, N-[7-cyano-2,3-dihydro-1,1-dioxido-6-(trifluoromethyl)benzo[b]thien-3-yl]-N-[2-(dimethylamino)ethyl]-3-(4-fluoro-3-methylphenyl)-5-methoxy- manufacturers
- Cmpd-A
-
- $4140.00
-
2026-05-26
- CAS:1446399-26-3
- Purity: 98.26%
- Supply Ability: 10g
|
| | Imidazo[1,2-a]pyridine-2-carboxamide, N-[7-cyano-2,3-dihydro-1,1-dioxido-6-(trifluoromethyl)benzo[b]thien-3-yl]-N-[2-(dimethylamino)ethyl]-3-(4-fluoro-3-methylphenyl)-5-methoxy- Basic information |
| | Imidazo[1,2-a]pyridine-2-carboxamide, N-[7-cyano-2,3-dihydro-1,1-dioxido-6-(trifluoromethyl)benzo[b]thien-3-yl]-N-[2-(dimethylamino)ethyl]-3-(4-fluoro-3-methylphenyl)-5-methoxy- Chemical Properties |
| density | 1.42±0.1 g/cm3(Predicted) | | pka | 8.13±0.28(Predicted) |
| | Imidazo[1,2-a]pyridine-2-carboxamide, N-[7-cyano-2,3-dihydro-1,1-dioxido-6-(trifluoromethyl)benzo[b]thien-3-yl]-N-[2-(dimethylamino)ethyl]-3-(4-fluoro-3-methylphenyl)-5-methoxy- Usage And Synthesis |
| Description | Cmpd-A is a time-dependent CENP-E inhibitor with potent antitumor activity. Cmpd-A inhibits the ATPase activity of the CENP-E motor domain, acting as a time-dependent inhibitor with an ATP-competitive-like behavior. Cmpd-A causes chromosome misalignment on the metaphase plate, leading to prolonged mitotic arrest. Treatment with Cmpd-A induces antiproliferation in multiple cancer cell lines. |
| | Imidazo[1,2-a]pyridine-2-carboxamide, N-[7-cyano-2,3-dihydro-1,1-dioxido-6-(trifluoromethyl)benzo[b]thien-3-yl]-N-[2-(dimethylamino)ethyl]-3-(4-fluoro-3-methylphenyl)-5-methoxy- Preparation Products And Raw materials |
|